Health Care M&A Weekly Deals, The Week Ending May 26, 2017

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.

This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.

Biotechnology
Acquirer Target Price
Bioverativ Inc. True North Therapeutics $400 million
Pierre Fabre S.A. Certain assets from Igenica Biotherapeutics N/A
Debiopharm International SA License to IMGN529/DEBIO 1562 $25 million
Merck & Co. Inc. License to tau protein antibody N/A

eHealth
Acquirer Target Price
Optima Healthcare Solutions Hospicesoft N/A

Hospitals
Acquirer Target Price
Global Medical REIT Inc. Carrus Specialty Hospital and Carrus Rehabilitation Hospital $26 million
Prime Healthcare Foundation Mission Regional Medical Center N/A

Laboratories, MRI and Dialysis
Acquirer Target Price
DaVita, Inc. Centrum Dializa II N/A

Long-Term Care
Acquirer Target Price
The Tanbic Company Parsons House Frisco N/A
Berkshire Health Systems Loomis House N/A

Medical Devices
Acquirer Target Price
Avery Dennison Corporation Finesse Medical Ltd. N/A
EnteroMedics Inc. BarioSurg, Inc. N/A

Pharmaceuticals
Acquirer Target Price
Recordati SpA License to Seloken in Europe $300 million
Elite Pharmaceuticals, Inc. ANDA for Trimipramine Maleate capsules N/A
Chiesi Farmaceutici SpA European subsidiary of Horizon Pharma $70 million

Physician Medical Groups
Acquirer Target Price
Harvest Partners, LP EyeCare Services Partners Holdings LLC N/A
Envision Healthcare Corporation Gwinnett Emergency Specialists P.C. N/A
Albemarle Eye Center Edenton Eye Care & Outer Banks Eye Care N/A

Other Services
Acquirer Target Price
BC Partners DentalPro N/A